» Articles » PMID: 37056344

Long Noncoding RNA SNHG15: A Promising Target in Human Cancers

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Apr 14
PMID 37056344
Authors
Affiliations
Soon will be listed here.
Abstract

As oncogenes or tumor suppressor genes, lncRNAs played an important role in tumorigenesis and the progression of human cancers. The lncRNA SNHG15 has recently been revealed to be dysregulated in malignant tumors, suggesting the aberrant expression of which contributes to clinical features and regulates various oncogenic processes. We have selected extensive literature focused on SNHG15 from electronic databases, including studies relevant to its clinical significance and the critical events in cancer-related processes such as cell proliferation, apoptosis, autophagy, metastasis, and drug resistance. This review summarized the current understanding of SNHG15 in cancer, mainly focusing on the pathological features, known biological functions, and underlying molecular mechanisms. Furthermore, SNHG15 has been well-documented to be an effective diagnostic and prognostic marker for tumors, offering novel therapeutic interventions in specific subsets of cancer cells.

Citing Articles

The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma.

Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S Epigenomics. 2025; 17(2):125-140.

PMID: 39829063 PMC: 11792803. DOI: 10.1080/17501911.2024.2442297.


High-Throughput Single-Nucleus RNA Profiling of Minimal Puncture FFPE Samples Reveals Spatiotemporal Heterogeneity of Cancer.

Jiang W, Zhang X, Xu Z, Cheng Q, Li X, Zhu Y Adv Sci (Weinh). 2024; 12(4):e2410713.

PMID: 39630113 PMC: 11789576. DOI: 10.1002/advs.202410713.


Plasma long non-coding RNAs as biomarkers for bone marrow infiltration and stage in diffuse large B-cell lymphoma.

Abdelhafiz A, Nabil R, Ghareeb M, Ibraheem D, Ali A, Elshazly S Int J Immunopathol Pharmacol. 2024; 38:3946320241292665.

PMID: 39393794 PMC: 11483759. DOI: 10.1177/03946320241292665.

References
1.
Zhang J, Wang L, Jiang J, Qiao Z . The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway. J Cell Biochem. 2020; 121(12):4699-4710. DOI: 10.1002/jcb.29474. View

2.
Wang M, Huang C, Gao W, Zhu Y, Zhang F, Li Z . MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma and via the MEK1-mediated ERK-MMP signaling pathway. Aging (Albany NY). 2022; 14(8):3540-3553. PMC: 9085224. DOI: 10.18632/aging.204028. View

3.
Kong Q, Qiu M . Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2017; 495(2):1594-1600. DOI: 10.1016/j.bbrc.2017.12.013. View

4.
Farooqi A, Fayyaz S, Poltronieri P, Calin G, Mallardo M . Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs. Semin Cancer Biol. 2020; 83:197-207. DOI: 10.1016/j.semcancer.2020.07.013. View

5.
Mi H, Wang X, Wang F, Li L, Zhu M, Wang N . SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381. Onco Targets Ther. 2020; 13:657-666. PMC: 6983676. DOI: 10.2147/OTT.S223321. View